circ_HMGCS1 modulates hepatocellular carcinoma chemoresistance via miR‐338‐5p/IL‐7 pathway

Abstract

AbstractHepatocellular cancer is one of the most serious types of cancer in the world, with high incidence and mortality rates. Most HCC patients with long‐term chemotherapy develop chemoresistance, leading to a poor prognosis. However, the underlying mechanism of circRNAs in HCC chemoresistance remains unclear. Our research found that circ_0072391(circ_HMGCS1) expression was significantly upregulated in cisplatin‐resistant HCC cells. The silence of circ_HMGCS1 attenuated the cisplatin resistance in HCC. Results showed that circ_HMGCS1 regulated the expression of miR‐338‐5p via acting as microRNA sponges. Further study confirmed that miR‐338‐5p regulated the expression of IL‐7. IL‐7 could remodel the immune system by improving T‐cell function and antagonising the immunosuppressive network. IL‐7 is an ideal target used to enhance the function of the immune system. circ_HMGCS1 exerts its oncogenic function through the miR‐338‐5p/IL‐7 pathway. Inhibition of circ_HMGCS1/miR‐338‐5p/IL‐7 could effectively attenuate the chemoresistance of HCC. IL‐7 might be a promising immunotherapy target for HCC cancer treatment.